Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Gevorderd CTCL: van richtlijn naar realiteit
15 jan 2026 om 19:30 | Lymfoom